Sotheby's is currently embroiled in a legal dispute, accused of not paying a $10.2 million commission related to the $510 million sale of its former New York headquarters. This lawsuit was initiated on April 9 in the New York State Supreme Court by Cushman & Wakefield, a prominent real estate firm.
The contention arises from Sotheby's 2025 sale of its longstanding property located at 1334 York Avenue to Weill Cornell Medicine. Cushman asserts that it played a crucial role in securing the medical institution as a tenant in 2023, a deal it claims established a basis for the eventual sale and triggered a contractual right to a 2 percent commission.
According to Cushman, Sotheby's has declined to fulfill this payment obligation, opting instead to retain the funds amidst increasing financial pressures. In response, Sotheby's has labeled the lawsuit as "baseless," expressing its intention to vigorously defend itself in court.
This legal challenge arrives at a particularly sensitive time for Sotheby's. Recent reports indicate that the auction house has been offering sellers interest--approximately 7 percent--to postpone payouts. This strategy is part of what Sotheby's describes as "extended settlement terms" introduced in 2025, aimed at navigating a cash flow crisis. Despite achieving total sales of $7.1 billion in 2025, the company reported a pre-tax loss of $248 million in 2024 and holds over $1 billion in client payables.
Additionally, Cushman claims it was kept uninformed about the progress of the deal, only discovering the sale through media reports. The firm accuses Sotheby's of undermining its contractual rights and denying it the commission associated with the transaction.
The York Avenue building symbolizes Sotheby's long journey of expansion and contraction. Originally purchased in 1980, it was sold in 2002 during a period of financial difficulty, only to be repurchased in 2009. Recently, Sotheby's has relocated its operations to Queens and moved its headquarters to the Breuer Building, reflecting a strategic effort to realign its presence in the market.